Female BALB/c mice (4–6 weeks old) were i.p. inoculated with three EV71 FCP-As (V1, V2, and V3) containing 200 U antigen. The sera were isolated and tested at 7, 14, 21, 28, 56 and 84 d post-inoculati
Background: Convalescent plasma is one of the treatment options for COVID-19 which is currently being investigated in many clinical trials. Understanding of donor and product characteristics is import
Evaluation of neuraminidase‐inhibiting (NI) and hemagglutination‐inhibiting (HI) antibody responses to seasonal inactivated influenza vaccines over 12 months.
Immunology Database and Analysis Portal2025-10-30 更新20
aPrimary or secondary DENV infection was determined as described in Methods. bThe current infecting serotype was determined as described in Methods. With the exception of two DHF/DSS cases (274, 233),